How can access to newly developed antibiotics be ensured while promoting their responsible use and preventing the development of further resistance?

May 23, 2023 ... Carbapenem Resistant Pseudomonas aeruginosa (CRPA) · P. aeruginosa causes an estimated 51,000 health care-associated infections in the U.S. ... Jul 12, 2018 ... P. aeruginosa is an opportunistic pathogen and it rarely affects healthy individuals. It can cause a wide range of infections, particularly in ... Dec 16, 2024 ... ... infection due to P aeruginosa. Secondary outcomes included all ... Pseudomonas aeruginosa infection. Infect Drug Resist. 2022; 15:655 ... The emergence of colistin-resistant Pseudomonas aeruginosa in cystic fibrosis (CF) patients, particularly after long-term inhalation treatments, has been ... Most pseudomonads known to cause disease in humans are associated with opportunistic infections. These include P aeruginosa, P fluorescens, P putida, P cepacia, ... Jul 5, 2018 ... aeruginosa. For many people, a Pseudomonas infection will only cause mild symptoms. However, if a person is in a hospital or has a weakened ... Pseudomonas bacteria, including Pseudomonas aeruginosa, are present throughout the world in soil and water. These bacteria favor moist areas, such as sinks ... The typing database contains nomenclature - allele definitions that provide an identifier for every unique allele sequence, and MLST profiles that index each ... Nov 29, 2023 ... Agent Characteristics Risk Group: RG-2 associated with human disease, rarely serious; preventive or therapeutic interventions often available. Pseudomonas aeruginosa is commonly found transiently on the skin, especially in the axillary and anogenital regions, and readily colonises ulcers and moist ...